Metastatic breast cancer: A regional audit of HER2 testing and trastuzumab access

6097 Background: Clinical trials have clearly established that patients receiving taxane-based chemotherapy for metastatic breast cancer (MBC) should be treated with trastuzumab if their tumour is ...